Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | MAOB | P27338 | 1/20 | 0.34 |
| ▸ | CASP3 | P42574 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 5/20 | 0.32 |
| ▸ | RAB9A | P51151 | 4/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.32 |
| ▸ | NPC1 | O15118 | 2/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.32 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.32 |
| ▸ | RELA | Q04206 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | MPO | P05164 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13023955 | 0.87 | RAB9A (0.33) | LMNAMAPTRAB9ANPSR1L3MBTL1 | |
| SCHEMBL13022828 | 0.87 | NPSR1 (0.36) | CASP3MAPTRAB9ANPSR1L3MBTL1 | |
| SCHEMBL13023920 | 0.87 | LMNA (0.35) | LMNAMAOBMAPTRAB9AL3MBTL1 | |
| SCHEMBL13023927 | 0.87 | MAPT (0.35) | MAOBCASP3MAPTRAB9ANPSR1 | |
| SCHEMBL13022124 | 0.84 | MAPT (0.35) | MAOBCASP3MAPTRAB9ANPSR1 | |
| SCHEMBL13022877 | 0.83 | NPSR1 (0.35) | CASP3MAPTRAB9ANPSR1NPC1 | |
| SCHEMBL13023934 | 0.82 | NPC1 (0.33) | MAPTRAB9ANPSR1L3MBTL1NPC1 | |
| SCHEMBL13022151 | 0.81 | NPSR1 (0.33) | MAOBMAPTRAB9ANPSR1L3MBTL1 | |
| SCHEMBL13023843 | 0.81 | LMNA (0.36) | LMNAMAOBCASP3MAPTRAB9A | |
| SCHEMBL13023911 | 0.80 | NPSR1 (0.40) | LMNACASP3MAPTRAB9ANPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100286360-A1 | POLYMER COMPOUND AND POLYMER LIGHT EMITTING DEVICE USING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-11-11 | — | — | US | disclosed |
| US-20100286360-A1 | POLYMER COMPOUND AND POLYMER LIGHT EMITTING DEVICE USING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-11-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100286360-A1 | POLYMER COMPOUND AND POLYMER LIGHT EMITTING DEVICE USING THE SAME | IGF1R, SCO2, CRY1 | LMNA 1808/4885MAOB 1349/4885CASP3 3934/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.